BIO 2015 Dispatches: Not a bubble, says EY
This article was originally published in Scrip
Executive Summary
Despite unprecedented growth in the biotechnology sector in 2014, EY's Global Life Science leader Glen Giovannetti says the market is not likely to implode, but he does expect the amount of money flowing into biotech to normalize over the coming year.